Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLHL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101927057 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC648761 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00528 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPACA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on